Resultados da pesquisa - cancer ((pre res) OR (pre pores)) (phila)

Pesquisas alternativas:
pre pores » pre pore (Expandir a Pesquisa), pre power (Expandir a Pesquisa), pre pre (Expandir a Pesquisa)
pre res » pre rcs (Expandir a Pesquisa), pre risc (Expandir a Pesquisa), care res (Expandir a Pesquisa)

21

Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials

Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials

Por Cecchini, Reena S., Costantino, Joseph P., Cauley, Jane A., Cronin, Walter M., Wickerham, D. Lawrence, Land, Stephanie R., Weissfeld, Joel L., Wolmark, Norman
Publicado em 2012

“...High body mass index (BMI) has been associated with an increased risk for breast cancer among...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

22

Sleep and Breathing … and Cancer?: A report from the University of California San Diego Sleep and Cancer Symposium, January 5–6(th), 2016 in La Jolla, CA.

Sleep and Breathing … and Cancer?: A report from the University of California San Diego Sleep and Cancer Symposium, January 5–6(th), 2016 in La Jolla, CA.

Por Owens, Robert L., Gold, Kathryn A., Gozal, David, Peppard, Paul E., Jun, Jonathan C., Dannenberg, Andrew J., Lippman, Scott M., Malhotra, Atul
Publicado no Cancer Prev Res (Phila) (2016)

“... the associations between cancer and sleep, utilizing mutually interactive epidemiologic studies, pre-clinical...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

23

Serum glycans as risk markers for non-small cell lung cancer

Serum glycans as risk markers for non-small cell lung cancer

Por Ruhaak, L. Renee, Stroble, Carol, Dai, Jianliang, Barnett, Matt, Taguchi, Ayumu, Goodman, Gary E., Miyamoto, Suzanne, Gandara, David, Feng, Ziding, Lebrilla, Carlito B., Hanash, Samir
Publicado no Cancer Prev Res (Phila) (2016)

“... lung cancer (NSCLC) cases from controls in pre-diagnostic samples using a previously validated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

24

Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer

Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer

Por Howe, Louise R., Brown, Powel H.
Publicado em 2011

“...)-positive and no effect for ER-negative cancer] and the risk of pre-invasive disease [ductal carcinoma...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

25

ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias

ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias

Por Hieken, Tina J, Carter, Jodi M, Hawse, John R, Hoskin, Tanya L, Bois, Melanie, Frost, Marlene, Hartmann, Lynn C, Radisky, Derek C, Visscher, Daniel W, Degnim, Amy C
Publicado no Cancer Prev Res (Phila) (2015)

“... effect in pre-menopausal women: the 20-year cumulative incidence of breast cancer was 0% for women <age...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

26

Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study

Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study

Por Feng, Tom, Sun, Xizi, Howard, Lauren E., Vidal, Adriana C., Gaines, Alexis R., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Publicado no Cancer Prev Res (Phila) (2015)

“...The role of metformin in prostate cancer chemoprevention remains unclear. REDUCE, which followed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

27

Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer

Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer

Por Burkhart, Deborah L., Morel, Katherine L., Wadosky, Kristine M., Labbé, David P., Galbo, Phillip M., Dalimov, Zafardjan, Xu, Bo, Loda, Massimo, Ellis, Leigh
Publicado no Cancer Prev Res (Phila) (2020)

“...Chemoprevention trials for prostate cancer (PCa) by androgen receptor or androgen synthesis...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

28

Clonal evolution in healthy and premalignant tissues: implications for early cancer interception strategies

Clonal evolution in healthy and premalignant tissues: implications for early cancer interception strategies

Por Rane, Jayant K., Frankell, Alexander M., Weeden, Clare E., Swanton, Charles
Publicado no Cancer Prev Res (Phila) (2023)

“..., giving rise to clones which, at times, can replace the entire surface area of tissues. Compared to cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

29

A prospective targeted serum metabolomics study of pancreatic cancer in postmenopausal women

A prospective targeted serum metabolomics study of pancreatic cancer in postmenopausal women

Por Jiao, Li, Maity, Suman, Coarfa, Cristian, Rajapakshe, Kimal, Chen, Liang, Jin, Feng, Putluri, Vasanta, Tinker, Lesley F., Mo, Qianxing, Chen, Fengju, Sen, Subrata, Sangi-Hyghpeykar, Haleh, El-Serag, Hashem B., Putluri, Nagireddy
Publicado no Cancer Prev Res (Phila) (2019)

“...To examine the association between metabolic deregulation and pancreatic cancer, we conducted a two...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

30

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence

Por Gruessner, Christine, Gruessner, Angelika, Glaser, Katherine, AbuShahin, Nisreen, Zhou, Yi, Laughren, Cynthia, Wright, Heather, Pinkerton, Samantha, Yi, Xiaofang, Stoffer, Jha'nae, Azodi, Masoud, Zheng, Wenxin, Chambers, Setsuko K.
Publicado em 2014

“... cancer development and (2) flutamide treatment of women at high risk (HR) for ovarian cancer may identify...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

31

Methylation-derived neutrophil-to-lymphocyte ratio and lung cancer risk in heavy smokers

Methylation-derived neutrophil-to-lymphocyte ratio and lung cancer risk in heavy smokers

Por Grieshober, Laurie, Graw, Stefan, Barnett, Matt J., Thornquist, Mark D., Goodman, Gary E., Chen, Chu, Koestler, Devin C., Marsit, Carmen J., Doherty, Jennifer A.
Publicado no Cancer Prev Res (Phila) (2018)

“... assessed the relationship between pre-diagnosis mdNLR and lung cancer risk in a nested case-control study...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

32

Complementary longitudinal serum biomarkers to CA125 for early detection of ovarian cancer

Complementary longitudinal serum biomarkers to CA125 for early detection of ovarian cancer

Por Simmons, Archana R., Fourkala, Evangelia Ourania, Gentry-Maharaj, Aleksandra, Ryan, Andy, Sutton, Margie N., Baggerly, Keith, Zheng, Hui, Lu, Karen H., Jacobs, Ian, Skates, Steven, Menon, Usha, Bast, Robert C.
Publicado no Cancer Prev Res (Phila) (2019)

“...Early detection of ovarian cancer has the potential to impact mortality. A multi-modal screening...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

33

Multi-omics analysis reveals adipose-tumor crosstalk in colorectal cancer patients

Multi-omics analysis reveals adipose-tumor crosstalk in colorectal cancer patients

Por Holowatyj, Andreana N., Haffa, Mariam, Lin, Tengda, Scherer, Dominique, Gigic, Biljana, Ose, Jennifer, Warby, Christy A., Himbert, Caroline, Abbenhardt-Martin, Clare, Achaintre, David, Boehm, Juergen, Boucher, Kenneth M., Gicquiau, Audrey, Gsur, Andrea, Habermann, Nina, Herpel, Esther, Kauczor, Hans-Ulrich, Keski-Rahkonen, Pekka, Kloor, Matthias, von Knebel-Doeberitz, Magnus, Kok, Dieuwertje E., Nattenmüller, Johanna, Schirmacher, Peter, Schneider, Martin, Schrotz-King, Petra, Simon, Thomas, Ueland, Per M., Viskochil, Richard, Weijenberg, Matty P., Scalbert, Augustin, Ulrich, Alexis, Bowers, Laura W., Hursting, Stephen D., Ulrich, Cornelia M.
Publicado no Cancer Prev Res (Phila) (2020)

“...Obesity and obesity-driven cancer rates are continuing to rise worldwide. We hypothesize...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

34

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Por Zhu, Claire S., Pinsky, Paul F., Cramer, Daniel W., Ransohoff, David F., Hartge, Patricia, Pfeiffer, Ruth M., Urban, Nicole, Mor, Gil, Bast, Robert C., Moore, Lee E., Lokshin, Anna E., McIntosh, Martin W., Skates, Steven J., Vitonis, Allison, Zhang, Zhen, Ward, David C., Symanowski, James T., Lomakin, Aleksey, Fung, Eric T., Sluss, Patrick M., Scholler, Nathalie, Lu, Karen H., Marrangoni, Adele M., Patriotis, Christos, Srivastava, Sudhir, Buys, Saundra S., Berg, Christine D.
Publicado em 2011

“... biomarker panels have been described for ovarian cancer, few studies used pre-diagnostic samples to assess...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

35

$The Parity-Associated Microenvironmental Niche in the Omental Fat Band is Refractory to Ovarian Cancer Metastasis$

The Parity-Associated Microenvironmental Niche in the Omental Fat Band is Refractory to Ovarian Cancer Metastasis

Por Cohen, Courtney A., Shea, Amanda A., Heffron, C. Lynn, Schmelz, Eva M., Roberts, Paul C.
Publicado em 2013

“...Ovarian cancer is an insidious and aggressive disease of older women, typically undiscovered prior...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

36

A PILOT STUDY OF A GRAPE SEED PROCYANIDIN EXTRACT FOR LUNG CANCER CHEMOPREVENTION

A PILOT STUDY OF A GRAPE SEED PROCYANIDIN EXTRACT FOR LUNG CANCER CHEMOPREVENTION

Por Mao, Jenny T., Lu, Qing-Yi, Xue, Bingye, Neis, Patricia, Zamora, Felix D., Lundmark, Laurie, Qualls, Clifford, Massie, Larry
Publicado no Cancer Prev Res (Phila) (2019)

“... were oncomirs previously reported to be downregulated by GSE, including LP, in pre-clinical studies...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

37

Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention

Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention

Por Miller, Jessica A., Pappan, Kirk, Thompson, Patricia A., Want, Elizabeth J., Siskos, Alexandros, Keun, Hector C., Wulff, Jacob, Hu, Chengcheng, Lang, Julie E., Chow, H-H. Sherry
Publicado no Cancer Prev Res (Phila) (2014)

“... anti-cancer properties in preclinical models with effects on multiple cellular targets at varying...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

38

Physical Activity and Survival in Postmenopausal Women with Breast Cancer: Results from the Women’s Health Initiative

Physical Activity and Survival in Postmenopausal Women with Breast Cancer: Results from the Women’s Health Initiative

Por Irwin, Melinda L., McTiernan, Anne, Manson, JoAnn E., Thomson, Cynthia A., Sternfeld, Barbara, Stefanick, Marcia L., Wactawski-Wende, Jean, Craft, Lynette, Lane, Dorothy, Martin, Lisa W., Chlebowski, Rowan
Publicado em 2011

“...Although studies have shown that physically active breast cancer survivors have lower all-cause...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

39

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

Por Kimura, Takashi, McKolanis, John R., Dzubinski, Lynda A., Islam, Kazi, Potter, Douglas M., Salazar, Andres M., Schoen, Robert E., Finn, Olivera J.
Publicado em 2012

“...Cancer vaccines based on human tumor associated antigens (TAA) have been tested in patients...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

40

Genetic Variations in microRNA-related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk

Genetic Variations in microRNA-related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk

Por Ye, Yuanqing, Wang, Kenneth K., Gu, Jian, Yang, Hushan, Lin, Jie, Ajani, Jaffer A., Wu, Xifeng
Publicado em 2008

“... may increase the risk for esophageal cancer, we assessed the associations between esophageal cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

[1]
Anterior
1
2
3
4
5
6
Seguinte
[6]